Publicacions en què col·labora amb José Ramón González Porras (9)

2013

  1. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

    Haematologica, Vol. 98, Núm. 3, pp. 437-443

2010

  1. The role of immature platelet fraction in acute coronary syndrome

    Thrombosis and Haemostasis

2007

  1. Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism

    Thrombosis Research, Vol. 119, Núm. 6, pp. 691-698

2006

  1. Medium-term results of percutaneous vertebroplasty in multiple myeloma

    European Journal of Haematology, Vol. 77, Núm. 1, pp. 7-13

  2. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation

    Blood Coagulation and Fibrinolysis, Vol. 17, Núm. 1, pp. 23-28

2005

  1. CD34+ cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation

    Leukemia and Lymphoma, Vol. 46, Núm. 2, pp. 177-183

2004

  1. Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: Results of a prospective study

    Bone Marrow Transplantation, Vol. 34, Núm. 8, pp. 729-738

  2. The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma

    Leukemia, Vol. 18, Núm. 4, pp. 856-863

2002

  1. Thalidomide in combination with cyclophosphamide and dexamethasone (thacydex) is effective in soft-tissue plasmacytomas [8]

    British Journal of Haematology